Myositis UK

Call Directions Website Contact the organisation

Myositis UK A Registered Charity in the UK since 1988 providing information and fundraising to actively fund research. Member of ARMA and NCVO.

Myositis UK is a national charity for the Inflammatory Myopathies; Juvenile Dermatomyositis, Dermatomyositis, Polymyositis, Necrotising Autoimmune Myopathy & Inclusion Body Myositis. Myositis UK (formerly Myositis Support Group) is a small national charity for the rare inflammatory myopathies; Juvenile Dermatomyositis, Dermatomyositis, Polymyositis and Inclusion Body Myositis. Over £800,000 has been spent on Research projects within the UK and abroad. Charity works with collaborations including UKMyoNet, JDRG, EUMyonet and IMOAC. Patient meeting for members held annually. Charity represented with a stand at Rheumatology and Neurology conferences in the UK.

21/09/2026

The 21st of September is World Myositis Day 🌎Those with Myositis live with a challenging condition every day, but today ...
21/09/2026

The 21st of September is World Myositis Day 🌎

Those with Myositis live with a challenging condition every day, but today is to highlight a group of rare conditions known collectively as the Inflammatory Myopathies. Myositis effects children & adults, symptoms include muscle weakness, lung & heart involvement & skin rashes.

It's hearting to see the growing number of patient organisations around the world supporting those with Myositis 😊

Information about the types of Myositis https://www.myositis.org.uk/myositis-info/conditions/

The Autumn edition of Myositis News (Myositis UK's newsletter) is now available to view online
09/09/2026

The Autumn edition of Myositis News (Myositis UK's newsletter) is now available to view online

See what Myositis UK publications are available to help you better understand the different types of myositis and how you can support.

The Myositis UK 2026 Conference is now available to view on YouTube
09/09/2026

The Myositis UK 2026 Conference is now available to view on YouTube

Share your videos with friends, family, and the world

ERN ReCONNET Webinar | Idiopathic Inflammatory Myopathies (IIMs)We are pleased to announce the upcoming ERN ReCONNET web...
07/09/2026

ERN ReCONNET Webinar | Idiopathic Inflammatory Myopathies (IIMs)
We are pleased to announce the upcoming ERN ReCONNET webinar:
“Fatigue in Patients with Myositis – Beyond Muscle Weakness”
Is fatigue still the great, overlooked challenge in the management of Idiopathic Inflammatory Myopathies (IIMs)?
Join our webinar to explore the complex and multifactorial nature of this symptom, one of the most disabling yet underestimated in patients with myositis, and discover how immune-mediated inflammation, altered energy metabolism, deconditioning, sleep disturbances, and psychosocial factors all contribute to its onset, while distinguishing it from muscle weakness through multidimensional assessment tools and patient-reported outcomes.
👉 Please note that the webinar is available with subtitles in 36 different languages.
Event Details:
• Date: 16th September 2026
• Time: 16:00 CET
• Target Audience: healthcare professionals, patients, caregivers and family members
• Dedicated to: Idiopathic Inflammatory Myopathies (IIMs)
• ✍️ Registration: rb.gy/f0uqhf
🎤 Speaker: Dr. Fabricio Espinosa-Ortega
🎙 Moderator: Dr. Olga Drápalová
⚙️ ERN ReCONNET IIMs Resources: https://reconnet.ern-net.eu/disease-iims/
🗞 Newsletter subscription: bit.ly/44wk7La
💻 Webinar Archive: https://reconnet.ern-net.eu/webinar/

🎓 ERN ReCONNET Webinar | Idiopathic Inflammatory Myopathies (IIMs)

We are pleased to announce the upcoming ERN ReCONNET webinar:
“Fatigue in Patients with Myositis – Beyond Muscle Weakness”

Is fatigue still the great, overlooked challenge in the management of Idiopathic Inflammatory Myopathies (IIMs)?
Join our webinar to explore the complex and multifactorial nature of this symptom, one of the most disabling yet underestimated in patients with myositis, and discover how immune-mediated inflammation, altered energy metabolism, deconditioning, sleep disturbances, and psychosocial factors all contribute to its onset, while distinguishing it from muscle weakness through multidimensional assessment tools and patient-reported outcomes.

👉 Please note that the webinar is available with subtitles in 36 different languages.

Event Details:
• Date: 16th September 2026
• Time: 16:00 CET
• Target Audience: healthcare professionals, patients, caregivers and family members
• Dedicated to: Idiopathic Inflammatory Myopathies (IIMs)
• ✍️ Registration: rb.gy/f0uqhf

🎤 Speaker: Dr. Fabricio Espinosa-Ortega
🎙 Moderator: Dr. Olga Drápalová

⚙️ ERN ReCONNET IIMs Resources: https://reconnet.ern-net.eu/disease-iims/
🗞 Newsletter subscription: bit.ly/44wk7La
💻 Webinar Archive: https://reconnet.ern-net.eu/webinar/

From: Manchester Myositis Research Group via InstagramLast month, a study was published in Rheumatology that provided so...
05/09/2026

From: Manchester Myositis Research Group via Instagram

Last month, a study was published in Rheumatology that provided some exciting new evidence relating to diet and myositis…

In the largest study of its kind, researchers explored relationships between Med diet adherence, physical health, function and symptoms of myositis.

What does the research tell us? Could the Med diet form part of a healthy diet for someone with myositis?

https://www.instagram.com/p/DczKx8Uit68/?utm_source=ig_web_copy_link&igsi=MzRlODBiNWFlZA==

Patient event in Bath 29th September 😊Register interest via link below
19/08/2026

Patient event in Bath 29th September 😊
Register interest via link below

Research Showcase: Royal National Hospital for Rheumatic Diseases – Bath Royal Literary and Scientific Institution, Tue 29 Sep 2026 - The RNHRD with BIRD are planning an event to showcase and inform patients (and anyone with an interest in rheumatic conditions) the current rheumatology research pr...

19/08/2026

Abcuro secure $66 million funding for IBM ulviprubart study

"Proceeds to support a potentially registrational clinical study in less severe inclusion body myositis (IBM) patients expected to begin in Q4 2026 and report top line results in 2H 2028"

"Ulviprubart showed a trend toward clinically meaningful slowing of disease progression in patients with less severe IBM in the previous Phase 2/3 MUSCLE study"

"Results from the recent Phase 2/3 MUSCLE study of ulviprubart in patients with IBM were presented at the 6th Global Conference on Myositis (GCOM) meeting in March 2026." (Myositis UK Trustee's attended).

https://abcuro.com/uncategorized/abcuro-announces-66-million-series-d-financing-to-advance-its-first-in-class-medicine-in-development-for-inclusion-body-myositis/

Another study that backs the advice for a mediterranean dietHigher mediterranean diet adherence was associated with more...
18/08/2026

Another study that backs the advice for a mediterranean diet

Higher mediterranean diet adherence was associated with more favourable patient-reported physical health, function, and symptom burden among individuals with idiopathic inflammatory myopathies (Myositis).

https://academic.oup.com/rheumatology/advance-article-abstract/doi/10.1093/rheumatology/keag424/8762018?

AbstractObjectives. The clinical relevance of Mediterranean diet (MedDiet) and determinants shaping adherence across disease phenotypes remain largely unex

Address

146 Newtown Road
Southampton
SO199HR

Opening Hours

Monday 10am - 3pm
Tuesday 10am - 3pm
Wednesday 10am - 3pm
Thursday 10am - 3pm
Friday 10am - 3pm

Telephone

023 8044 9708

Alerts

Be the first to know and let us send you an email when Myositis UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organisation

Send a message to Myositis UK:

Shortcuts

Share